Biotechnology Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya Read more
Biotechnology Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment Read more
Biotechnology Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting Read more
